AstraZeneca also retains the advantage of its patent on the Turbuhaler delivery device used to administer Symbicort, which is valid in the EU until 2019. ...
Through innovative respiratory products, including SYMBICORT®, PULMICORT RESPULES®, PULMICORT TURBUHALER®, and RHINOCORT AQUA®, AstraZeneca is providing ...
The introduction of Symbicort Turbuhaler as a Single inhaler for Maintenance and Reliever Therapy (SMART) is a much simpler and practical way of managing ...